Gao R, Zeng J, Yang K, Wang P, Zhou S
World J Orthop. 2025; 16(2):102101.
PMID: 40027965
PMC: 11866113.
DOI: 10.5312/wjo.v16.i2.102101.
Naranjo-Rojas A, Perula-de Torres L, Cruz-Mosquera F, Molina-Recio G
J Med Internet Res. 2025; 27():e65888.
PMID: 39761550
PMC: 11747540.
DOI: 10.2196/65888.
Fan M, Fang Y, Chen J, Zhong X, Zhang N, Zeng Z
Int J Chron Obstruct Pulmon Dis. 2025; 19:2763-2773.
PMID: 39759460
PMC: 11697644.
DOI: 10.2147/COPD.S482234.
Selvam A, Durai S, Y D, M R, Radhakrishnan P
Cureus. 2024; 16(11):e74619.
PMID: 39735077
PMC: 11680464.
DOI: 10.7759/cureus.74619.
Feng M, Liu Y, Li Q, Yang X, Wei F, Cheng H
BMC Pulm Med. 2024; 24(1):634.
PMID: 39732680
PMC: 11682637.
DOI: 10.1186/s12890-024-03454-3.
People Living with Chronic Obstructive Pulmonary Disease (COPD) and Inhalers: Insights and Suggestions from a Human Factors Study on NEXThaler.
Scichilone N, Whittamore A, White C, Nudo E, Savella M, Lombardini M
Patient Prefer Adherence. 2024; 18:2415-2423.
PMID: 39650572
PMC: 11624662.
DOI: 10.2147/PPA.S483993.
Poor treatment outcomes of acute exacerbations of chronic obstructive pulmonary disease and their associated factors among admitted patients in East Gojjam, 2023.
Getnet M, Afenigus A, Gete M, Emrie A, Tsegaye D
Front Med (Lausanne). 2024; 11:1434166.
PMID: 39635589
PMC: 11615673.
DOI: 10.3389/fmed.2024.1434166.
Hospitalisation patterns for respiratory diseases in Australia: an ecological study.
Alrajeh A, Naser A, Aldabayan Y, Alqahtani J, Aldhahir A, Siraj R
BMJ Open. 2024; 14(11):e084286.
PMID: 39608993
PMC: 11603736.
DOI: 10.1136/bmjopen-2024-084286.
Frequency of Asymptomatic Deep Vein Thrombosis in Hospitalized Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease (COPD).
Ahmed I, Khan K, Akhter N, Amanullah Shah S, Hidayatullah S, Chawla D
Cureus. 2024; 16(9):e69858.
PMID: 39435215
PMC: 11493205.
DOI: 10.7759/cureus.69858.
Factors Influencing Prevalence, C-reactive Protein Levels, and Lymphocyte Counts in Chronic Obstructive Pulmonary Disease Patients With Metabolic Syndrome.
Mahato B, Nigoskar S, Lakshmi L, Zephy D
Cureus. 2024; 16(8):e68122.
PMID: 39347252
PMC: 11438483.
DOI: 10.7759/cureus.68122.
The Biomarker Potential of the Neutrophil-to-Lymphocyte Ratio in Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vaishnav B, Pailla R, Wadivkar A, Ummaleti H, Doshi N
Cureus. 2024; 16(8):e66750.
PMID: 39268318
PMC: 11391329.
DOI: 10.7759/cureus.66750.
Mortality Outcomes and Contributing Risk Factors in Patients with Hospital-Associated Disability.
Jo S, Lee S, Min H, Kim H, Kong H
J Clin Med. 2024; 13(16).
PMID: 39200940
PMC: 11355630.
DOI: 10.3390/jcm13164798.
Increased Pneumonia Risk Associated with Concomitant Use of Inhaled Corticosteroids and Benzodiazepines: A Pharmacovigilance Analysis.
Ma J, Liu Y, Sun Y, Guo C, Yang G
Lung. 2024; 202(5):673-681.
PMID: 39191908
DOI: 10.1007/s00408-024-00741-y.
Progesterone (P4) ameliorates cigarette smoke-induced chronic obstructive pulmonary disease (COPD).
Xie B, Chen Q, Dai Z, Jiang C, Chen X
Mol Med. 2024; 30(1):123.
PMID: 39138434
PMC: 11323532.
DOI: 10.1186/s10020-024-00883-y.
Identification of novel biomarkers related to neutrophilic inflammation in COPD.
Huang Y, Niu Y, Wang X, Li X, He Y, Liu X
Front Immunol. 2024; 15:1410158.
PMID: 38873611
PMC: 11169582.
DOI: 10.3389/fimmu.2024.1410158.
Clinician Views of Proactive Tobacco Treatment Programs: A Qualitative Evaluation.
Melzer A, Campbell M, Hagedorn H, Fu S
J Gen Intern Med. 2024; 39(11):2079-2086.
PMID: 38831247
PMC: 11306907.
DOI: 10.1007/s11606-024-08834-3.
Defining the role of exertional hypoxemia and pulmonary vasoconstriction on lung function decline, morbidity, and mortality in patients with chronic obstructive lung disease - the PROSA study: rationale and study design.
Boger R, Hannemann J
BMC Pulm Med. 2024; 24(1):262.
PMID: 38816826
PMC: 11137990.
DOI: 10.1186/s12890-024-03074-x.
Development of a disease-specific health utility score for chronic obstructive pulmonary disease from a discrete choice experiment patient preference study.
Jones B, Ryan M, Cook N, Gutzwiller F
Int J Technol Assess Health Care. 2024; 40(1):e30.
PMID: 38695141
PMC: 11569910.
DOI: 10.1017/S0266462324000242.
Human genetic associations of the airway microbiome in chronic obstructive pulmonary disease.
Gao J, Yang Y, Xiang X, Zheng H, Yi X, Wang F
Respir Res. 2024; 25(1):165.
PMID: 38622589
PMC: 11367891.
DOI: 10.1186/s12931-024-02805-2.
The 2021 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines and the outpatient management: Examining physician adherence and its effects on patient outcome.
Orozco R, Rodriguez D, Hunter K, Roy S
J Family Med Prim Care. 2024; 13(2):736-742.
PMID: 38605771
PMC: 11006038.
DOI: 10.4103/jfmpc.jfmpc_1397_23.
